Publications by authors named "David Holtgrave"

Claim this Profile
E
Economic Evaluation of a Naloxone Distribution and Training via a State-Level Opioid Overdose Prevention Program, New York State, April 2023 to March 2025.
David R Holtgrave, Lucila Zamboni, Elizabeth Schady, Allan Clear, Ju Nyeong Park

J Public Health Manag Pract· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiologic and Economic Impacts of Halting National HIV Prevention Efforts.
David R Holtgrave

AIDS Behav· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits of reaching the National 2025 goal for reduction in fatal drug overdoses.
David R Holtgrave, James V McDonald

Ann Epidemiol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of States' Methods for Estimating Nonfatal Overdose, United States, 2021.
Christian E Johnson, David R Holtgrave, Megan Catlin, Rahul Gupta

Public Health Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Public health implications of recent declines in fatal drug overdoses in New York State and the United States.
David R Holtgrave, Allan Clear, James V McDonald

Health Aff Sch· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Cost and Cost‑Effectiveness of Incentives for Viral Suppression in People Living with HIV.
Laura J Dunlap, Stephen Orme, Gary A Zarkin, David R Holtgrave, Catherine Maulsby

AIDS Behav· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical and Public Health Imperatives of Xylazine. Reply.
Rahul Gupta, David R Holtgrave, Michael A Ashburn

N Engl J Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing an Approach for Designation of Evolving and Emerging Drug Threats.
Michael A Ashburn, David R Holtgrave, Richard J Baum, Rahul Gupta

Health Secur· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
Xylazine - Medical and Public Health Imperatives.
Rahul Gupta, David R Holtgrave, Michael A Ashburn

N Engl J Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 2023 Agenda for Substance Use Prevention and Treatment in the US.
Rahul Gupta, Nicholas F Wright, David R Holtgrave

JAMA· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
States' Methods for Capturing and Reporting Local Responses to Suspected Nonfatal Drug Overdoses.
Christian Johnson, Megan Catlin, Lisa Sinow, Rahul Gupta, David R Holtgrave

JAMA· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
US Tracking System for Nonfatal Drug Overdoses-Reply.
Rahul Gupta, David R Holtgrave

JAMA· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transforming Management of Opioid Use Disorder with Universal Treatment.
Rahul Gupta, Rachel L Levine, Javier A Cepeda, David R Holtgrave

N Engl J Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A National Tracking System for Nonfatal Drug Overdoses.
Rahul Gupta, David R Holtgrave

JAMA· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining the Most Appropriate Use of Available Regimens for HIV Preexposure Prophylaxis.
David R Holtgrave, Ronald O Valdiserri

Ann Intern Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost and Cost-Effectiveness of Incentives for Viral Suppression in People Living with HIV.
Laura J Dunlap, Stephen Orme, Gary A Zarkin, David R Holtgrave, Catherine Maulsby

AIDS Behav· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advocacy, activism, and lobbying: How variations in interpretation affects ability for academia to engage with public policy.
Nasreen S Jessani, Brenton Ling, Carly Babcock, Akshara Valmeekanathan, David R Holtgrave

PLOS Glob Public Health· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Widespread and Frequent Testing is Essential to Controlling Coronavirus Disease 2019 (COVID-19) in the United States.
Eli S Rosenberg, David R Holtgrave

Clin Infect Dis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status - New York, May 3-July 25, 2021.
Eli S Rosenberg, David R Holtgrave, Vajeera Dorabawila, MaryBeth Conroy, Danielle Greene

MMWR Morb Mortal Wkly Rep· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential Benefits of Expanded COVID-19 Surveillance in the US.
David R Holtgrave, Sten H Vermund, Leana S Wen

JAMA· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status - New York, May 3-July 25, 2021.
Eli S Rosenberg, David R Holtgrave, Vajeera Dorabawila, MaryBeth Conroy, Danielle Greene

MMWR Morb Mortal Wkly Rep· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintaining a Focus on Health Equity During the COVID-19 Vaccine Rollout.
Erika G Martin, Guthrie S Birkhead, David R Holtgrave

J Public Health Manag Pract· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Medicaid Expansions on HIV Diagnoses and Pre-Exposure Prophylaxis Use.
Bita Fayaz Farkhad, David R Holtgrave, Dolores Albarracín

Am J Prev Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State.
James M Tesoriero, Carol-Ann E Swain, Jennifer L Pierce, Lucila Zamboni, Meng Wu, David R Holtgrave

JAMA Netw Open· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated COVID-19 outcomes among persons living with diagnosed HIV infection in New York State: Results from a population-level match of HIV, COVID-19, and hospitalization databases.
James M Tesoriero, Carol-Ann E Swain, Jennifer L Pierce, Lucila Zamboni, Meng Wu, David R Holtgrave

medRxiv· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis